46
MEDYA
TR
EN
Home
Genel
News Detail
Morning Star
June 1, 2026
|
03:29
ImmVira Reports 100% Complete Response Rate at 9 Months in Bladder Carcinoma in Situ with MVR-T3011 at ASCO
...
Full Story at Source
Related News
Week Ahead for FX, Bonds: U.S. Jobs, ISM Data in Focus
Week Ahead for FX, Bonds: U.S. Jobs, ISM Data in -2
Greatland Approves $765 Million Havieron Gold-Copper Project
MICROIP to Debut "AI Vehicle System Business Group" and Edge AI Innovations at COMPUTEX 2026
